GlassScriptPhysician profile
Gregg K Carr
NPI 1528112885
$7,341.15
in general payments reported to CMS, 2019-2025
37 companies · $500 in 2025
The $500 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,594 · 2020: $516 · 2021: $424 · 2022: $579 · 2023: $3,030 · 2024: $698 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,126 · Travel and Lodging: $1,953 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,125.51 |
| Travel and Lodging | $1,952.75 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,782.27 | 2019-2024 | Blueprint Patient Specific Instrumentation, Duramatrix |
| Prime Surgical, LLC | $1,413.70 | 2023-2025 | |
| Arthrex, INC. | $792.16 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $412.51 | 2022-2025 | Iovera, Exparel, Zilretta |
| Pacira Therapeutics, INC. | $409.68 | 2019-2021 | |
| Horizon Therapeutics Plc | $268.41 | 2019-2020 | |
| Acumed LLC | $202.70 | 2022 | |
| Smith+Nephew, INC. | $201.28 | 2020-2024 | |
| Endo Pharmaceuticals INC. | $181.85 | 2020-2024 | Xiaflex |
| Bioventus LLC | $143.22 | 2019-2021 | |
| Djo, LLC | $140.54 | 2020-2023 | Donjoy |
| Ethicon US, LLC | $127.83 | 2021-2024 | Vistaseal, Dermabond, Dermabond Prineo |
| Boston Scientific Corporation | $123.27 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Heron Therapeutics, INC. | $119.99 | 2024 | Zynrelef |
| Depuy Synthes Sales INC. | $119.48 | 2022-2025 | Orthovisc, Na |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $86.38 | 2019-2025 | |
| Abbott Laboratories | $82.54 | 2021-2022 | |
| Convatec INC. | $74.26 | 2020-2024 | |
| Novo Nordisk INC | $68.44 | 2020-2024 | Ozempic |
| Ferring Pharmaceuticals INC. | $64.54 | 2021-2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $56.83 | 2025 | |
| Providence Medical Technology, INC. | $49.96 | 2025 | |
| Novocure INC. | $46.24 | 2025 | |
| Ge Healthcare | $43.58 | 2021 | |
| Avanos Medical | $41.39 | 2022-2024 | Trivisc Sodium Hyaluronate |
| Si-Bone, INC. | $39.72 | 2020-2025 | |
| Zimmer Biomet Holdings, INC. | $36.98 | 2020 | |
| Sanofi-Aventis U.S. LLC | $34.93 | 2019-2023 | |
| Orthofix Medical, INC. | $34.46 | 2022-2023 | Physio-Stim |
| Pfizer INC. | $24.94 | 2019 | |
| Baudax Bio INC. | $23.82 | 2021 | |
| Orthogenrx INC. | $19.88 | 2020 | |
| Vericel Corporation | $19.68 | 2019 | |
| Kerecis Limited | $14.29 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Amarin Pharma, INC. | $14.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.40 | 2022 | |
| Sonex Health, INC. | $12.00 | 2024 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregg Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.